Intuitive Surgical, Inc.

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 15:15:26 02/07/2024 BST			5-day change	1st Jan Change
434.6 ^USD	-0.37%		-1.71%	+28.86%

02:02pm	Evercore ISI Adjusts Price Target on Intuitive Surgical to $425 From $385, Maintains In-line Rating	MT
08:00am	Creo Medical Group PLC Provides Update in Relation to the Multi-Year Collaboration Agreement with Intuitive Surgical Inc	CI

Intuitive Surgical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2019

January 23, 2020 at 09:09 pm

Intuitive Surgical, Inc. announced earnings results for the fourth quarter ended December 31, 2019. For the fourth quarter, the company announced total revenue was USD 1,277.7 million compared to USD 1,046.5 million a year ago. Operating income was USD 397.6 million compared to USD 332 million a year ago. Net income was USD 357.7 million compared to USD 292.5 million a year ago. Basic earnings per share was USD 3.09 compared to USD 2.56 a year ago. Diluted earnings per share was USD 2.99 compared to USD 2.45 a year ago. For the full year, total revenue was USD 4,478.5 million compared to USD 3,724.2 million a year ago. Operating income was USD 1,374.5 million compared to USD 1,199.4 million a year ago. Net income was USD 1,379.3 million compared to USD 1,127.9 million a year ago. Basic earnings per share was USD 11.95 compared to USD 9.92 a year ago. Diluted earnings per share was USD 11.54 compared to USD 9.49 a year ago.

Latest news about Intuitive Surgical, Inc.

Evercore ISI Adjusts Price Target on Intuitive Surgical to $425 From $385, Maintains In-line Rating	01:02pm	MT
Creo Medical Group PLC Provides Update in Relation to the Multi-Year Collaboration Agreement with Intuitive Surgical Inc	07:00am	CI
RBC Capital Raises Intuitive Surgical Price Target to $475 From $432, Maintains Outperform Rating	06-21	MT
BTIG Adjusts Price Target on Intuitive Surgical to $451 From $421	06-21	MT
Three companies to bet on medical AI	06-10
Intuitive Surgical Secures US FDA Approval for Revised da Vinci Xi and X Labeling	06-05	MT
Intuitive Surgical, Inc. Announces FDA Clearance of Revised Da Vinci Xi and X Labeling on Radical Prostatectomy	06-05	CI
Intuitive Surgical Insider Sold Shares Worth $1,005,613, According to a Recent SEC Filing	06-04	MT
Intuitive Surgical Insider Sold Shares Worth $1,021,200, According to a Recent SEC Filing	05-17	MT
Everlasting momentum	05-16
ANALYST RECOMMENDATIONS : Ecolab, Texas Instruments, Cisco, Britvic, Shopify...	05-16
Transcript : Intuitive Surgical, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM	05-15
Intuitive Surgical Insider Sold Shares Worth $649,420, According to a Recent SEC Filing	05-06	MT
Intuitive Surgical, Inc. Announces Committee Changes	04-30	CI
Intuitive Surgical Insider Sold Shares Worth $695,293, According to a Recent SEC Filing	04-30	MT
Intuitive Elects Lewis Chew as Board of Directors	04-26	CI
Intuitive Surgical Insider Sold Shares Worth $741,398, According to a Recent SEC Filing	04-24	MT
Intuitive Surgical Insider Sold Shares Worth $1,971,160, According to a Recent SEC Filing	04-24	MT
Health Care Shares Gain on Earnings -- Health Care Roundup	04-19	DJ
Global markets live: P&G, Amex, Blackstone, Apple, Tesla...	04-19
Piper Sandler Adjusts Intuitive Surgical Price Target to $435 From $425	04-19	MT
Jefferies & Co Adjusts Intuitive Surgical Price Target to $375 From $365	04-19	MT
Tranche Update on Intuitive Surgical, Inc.'s Equity Buyback Plan announced on February 2, 2015.	04-19	CI
Deutsche Bank Adjusts Price Target on Intuitive Surgical to $390 From $370	04-19	MT
BTIG Research Adjusts Intuitive Surgical Price Target to $421 From $412	04-19	MT

Chart Intuitive Surgical, Inc.

Duration

Period

More charts

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.

Sector

Advanced Medical Equipment & Technology

Calendar

17/07/2024 - Q2 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Intuitive Surgical, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

436.2 USD

Average target price

426.5 USD

Spread / Average Target

-2.24%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INTUITIVE SURGICAL, INC.	+28.86%	155B
THERMO FISHER SCIENTIFIC	+1.38%	207B
DANAHER CORPORATION	+3.88%	181B
BOSTON SCIENTIFIC CORPORATION	+31.57%	112B
SIEMENS HEALTHINEERS AG	+1.60%	64.42B
EDWARDS LIFESCIENCES CORPORATION	+18.83%	54.38B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-1.92%	47.43B
AGILENT TECHNOLOGIES, INC.	-8.34%	37.17B
GE HEALTHCARE TECHNOLOGIES INC.	-1.39%	34.81B
RESMED, INC.	+9.76%	27.46B

Other Advanced Medical Equipment & Technology